Effects of traditional Chinese medicine combined with chemotherapy for extensive-stage small-cell lung cancer patients on improving oncologic survival: study protocol of a multicenter, randomized, single-blind, placebo-controlled trial

BACKGROUND: Extensive-stage small-cell lung cancer (ES-SCLC) is characterized by extensive metastases, aggressive progression, and poor prognosis. Chemotherapy is applied as a preferred first-line regimen for ES-SCLC, but inadequate for improving its overall survival. Traditional Chinese medicine (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuyi, Yu, Mingwei, Liu, Zishen, Zhang, Yi, Li, Qiwei, Yang, Guowang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265049/
https://www.ncbi.nlm.nih.gov/pubmed/34238342
http://dx.doi.org/10.1186/s13063-021-05407-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265049/
https://www.ncbi.nlm.nih.gov/pubmed/34238342
http://dx.doi.org/10.1186/s13063-021-05407-1

Ejemplares similares